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Abstract. Background: Maternal syphilis causes poor birth outcomes, including congenital syphilis. Testing and
treatment of partners prevents reinfection, but strategies to improve partner attendance are failing. The aim of this study
was to determine the effectiveness of three partner notification strategies. Methods: Pregnant women with a positive
point-of-care treponemal test at three antenatal clinics (ANCs) in Kampala, Uganda, were randomised 1 : 1 : 1 to receive
either notification slips (NS; standard of care), NS and a text messages (SMS) or NS and telephone calls. The primary
outcome was the proportion of partners who attended the ANC and were treated for syphilis. Results: Between 2015
and 2016, 17 130 pregnant women were screened; 601 (3.5%) had a positive treponemal result, and 442 were enrolled in
the study. Only 81 of 442 partners (18.3%; 23/152 (15.1%), 31/144 (21.5%) and 27/146 (18.5%) in the NS only, NS +
SMS and NS + telephone call groups respectively) attended an ANC for follow-up; there were no significant differences
between the groups. Twelve per cent of women attended the ANC with their male partner, and this proportion increased
over time. Partner non-treatment was independently associated with adverse birth outcomes (odds ratio 2.75; 95%
confidence interval 2.36–3.21; P < 0.001). Conclusions: Only 18.3% of partners of pregnant women who tested
positive for syphilis received treatment. Female partners of non-attendant men had worse birth outcomes. Encouraging
men to accompany women to the ANC and testing both may address the urgent need to treat partners of pregnant women
in sub-Saharan Africa to reduce poor fetal outcomes.
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Introduction
There are nearly 1 million cases of maternal syphilis globally
annually,1 causing adverse outcomes (low birthweight,
stillbirth, preterm delivery and congenital syphilis) in up
to 50% of untreated pregnancies.2,3 Screening and treatment
with single-dose benzathine penicillin for pregnant women
is effective, inexpensive and demonstrated to be cost-
effective.4,5 In sub-Saharan Africa (SSA), it is estimated
that universal antenatal screening could reduce the annual
number of stillbirths, neonatal deaths and cases of
congenital syphilis by up to 64 000, 25 000 and 32 000
respectively. Newer syphilis and combined HIV–syphilis
point-of-care tests (POCT) help increase syphilis testing in
pregnancy across the region.6 Unless infected male partners of
pregnant mothers are treated, reinfection later in the index
pregnancy or subsequent pregnancies may occur. In Uganda,
national health surveys show that 1.8% of adults aged
15–49 years have syphilis, and in 1% of couples both
partners are infected.7 Antenatal clinic (ANC) estimates are
slightly higher, at 2.1–3.0%; neonatal mortality is 2.5%, with
syphilis an important driver of adverse maternofetal
outcomes.8
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Partner notification (PN) has been used since the 19th
century for sexually transmissible infection (STI) control9
and aims to ‘close the loop’ of infection by ensuring all
potentially infected partners of the index case are identified
and treated. Different PN options are shown in
Table 1. PN approaches have been studied extensively in
resource-rich settings,10,11 but there is little documentation of
PN in Africa, especially for syphilis. A 2013 Cochrane review
of PN randomised control trials (RCTs)12 examined 24 studies,
four of which were conducted in Africa. Only one of the
24 studies in that review, completed more than 20 years ago
in the US,13 examined PN strategies in syphilis. PN in
resource-limited settings (RLS), such as SSA, is primarily
accomplished through index patient notification because
provider-oriented PN is costly;14,15 this approach is
encouraged by the World Health Organization (WHO).16
The willingness of index patients to notify their partners
has been shown to be high in SSA (58% in Uganda,17 50%
in Rwanda18 and 93% in Zimbabwe15). Furthermore, studies
revealed that client counselling in Zambia19 and Zimbabwe15
increased PN for STIs. In Uganda, lower rates (25–34%) of
partners attending for treatment have been observed,17,20
including an attendance rate of 34.5% observed by our team
at the Infectious Diseases Institute (IDI), Kampala for syphilis
PN.21 A 2010 review of PN strategies in RLS recommended
index patient PN with counselling, but recognised the
difficulty of implementation in such settings, with limited
counsellors and lack of privacy.14 A post-appointment
follow-up interaction with index cases (in person or by
telephone) has been shown to increase uptake of PN in
gonorrhoea22 and is a standard practice in HIV PN in SSA
(including Uganda).23
Alam et al.14 also proposed studies using mobile phone
technology to support PN, which is attractive given the high
levels of access to mobile phones in SSA. Forty-eight per cent
of Ugandans have a mobile phone subscription.24 However,
mHealth studies in STIs are primarily pilot studies and
efficacy data are lacking.11,25 In order for PN through short
messaging services (SMS), or text messages, to be viable
ethically, confidentiality issues must be overcome.26,27 SMS
to index patients is ethically uncomplicated and may be an
inexpensive way to encourage index patients to inform their
partners in RLS, as has proven beneficial in high-income
countries.28
We designed the Syphilis Treatment of Partners (STOP)
trial to provide a low-cost, partially automated addition to
improve on existing index case PN strategies of the Uganda
Ministry of Health (paper notification slips). The approach was
based on experience gained in PN at IDI with targeted
counselling and standard of care (SOC; 58% informed their
partner),21 as well as from other African studies on index case
PN.15,29 The opportunity presented by increased mobile phone
penetration could allow for inexpensive follow-up calls and
automated SMS with a view to increasing partner attendance
without large time and financial burdens. However, we wanted
to avoid contacting partners directly due to confidentiality
issues, so we added an additional post-test contact to the index
case to increase PN. We anticipated that many of the barriers
and facilitators in previously published STI and HIV studies
would be similar for syphilis. We included both telephone and
SMS because we speculated that deferential attitudes to
healthcare providers (HCPs) may make HCP-initiated
telephone calls more effective than SMS, but SMS are
cheaper and therefore worth exploring. The aim of the
study was to compare the proportion of partners who
reported to the clinic for syphilis testing (and treatment)
when syphilis-positive pregnant women were given only PN
slips (SOC), compared with SOC plus SMS reminders or SOC
plus telephone call reminders.
Methods
Participant recruitment
Between January 2015 and February 2016 pregnant women
were identified in ANCs at Mulago Hospital and Kasangati
Health Centre IV, both of which are Ministry of Health-run
centres with busy ANCs, and the IDI Adult Infectious Disease
Clinic, a private, not-for-profit clinic with an attached ANC in
Kampala, Uganda. Potential participants were identified and
approached by study staff. Screening was undertaken for
syphilis using point-of-care (POC) lateral flow tests (SD
Bioline; Standard Diagnostics, Gyeonggi-do, Republic of
Korea). HIV status was established by self-report and, if
unknown, women were offered testing using the rapid
sequential algorithm. Those found to be positive were
referred to HIV services if not previously in care. Women
with a positive pregnancy test and treponemal antibody rapid
POC test (POCT) were eligible for inclusion in the study. Other
inclusion criteria were age >18 years or age 14–17 years and
being a mature and emancipated minor (as defined by Ugandan
National Science and Technology guidelines; https://
www.uncst.go.ug/download/national-guidelines-for-research-
involving-humans/, accessed 21 January 2020), having a known
sexual partner, having access to a mobile phone and being
willing and able to use and receive SMS or telephone calls.
Exclusion criteria were illiteracy, inability to use a mobile
Table 1. Types of partner notification (PN)
EPT, expedited partner therapy; HCW, healthcare worker
Type of PN Contacting index case Follow-up
Provider-oriented methods HCW or other third party
Patient-oriented methods Index patients
Mixed methods Index patients HCW if index patient fails to notify
EPT Index case provided with antibiotics
to give to partner
Possible HCW follow-up
Low partner attendance for antenatal syphilis Sexual Health 215
phone and confirmed neurosyphilis. Potential participants were
offered information by study nurses and counsellors and
examined to exclude neurosyphilis. Women were treated
with 2.4 MU, i.m., benzathine penicillin G (BPG; in case
of allergy, women were treated with azithromycin 2 g, p.o.).
Participants provided informed written consent for
randomisation and for temporary specimen (blood) storage.
Serum was batched for rapid plasma reagin (RPR) testing
with titre confirmation at the Walter Reed Research
Laboratory in Kampala.
Women who attended with their partners were offered
testing for HIV and syphilis, but were not included in the
study because male partners were notified and treated for
syphilis on the same day if their partner had a positive test.
Randomisation
Participants were randomised by a computer-generated block
randomisation algorithm of different sized blocks in a ratio of
1 : 1 : 1 by an independent member of the IDI statistics team.
The randomisation schedule was provided to the site in a box
of sequentially numbered, opaque, sealed envelopes to the
enrolling study nurses. The sequential randomisation codes
were recorded on the study entry case report form to ensure
randomisation adherence. All participants were given a written
PN slip.
Intervention
The three study arms consisted of SOC (written PN slip), SOC
plus SMS reminders and SOC plus telephone call reminders.
Standard of care
The PN slip was given to the pregnant female participant on
the day she received her syphilis test results. The woman was
asked to give the slip to her sexual partner(s) and encourage
them to attend the STI clinic for syphilis management. The PN
slip contained only a code number and no identifiable features.
SMS reminders and notification slip for partner screening
In this group, in addition to SOC, participants
received weekly SMS reminders to encourage their partners
to attend the STI clinic for syphilis testing for up to 8 weeks
after the woman’s initial positive syphilis test. The participant
ID code number was written on the notification slip, which
partners were asked to bring to the clinic, and in the SMS
reminders. The script for the SMS is given in Table S1,
available as Supplementary Material to this paper.
Telephone call reminders and notification slip for
partner screening
In this group, in addition to SOC, participants received
a weekly telephone call for up to 8 weeks after initial
syphilis diagnosis from a nurse to remind them to encourage
their partners to attend the STI clinic for syphilis testing (see
Table S1 for the telephone call script). The participant ID code
number was written on the notification slip, which partners
were asked to return to the clinic, and was also given to the
participant by nurse during the telephone calls.
Follow-up
All participants were encouraged to attend the ANC every
4 weeks until delivery. Notification slips were duplicated,
with one copy to the pregnant woman and the other held in
the clinic. On partner return, the slips were matched and used for
linkage. The one postpartum study visit was conducted within
3 months of the end of pregnancy to assess clinical status, signs
and symptoms, antibiotic side effects and adverse pregnancy
outcomes as reported by the mothers, as well as to take a sample
for serum storage. When possible, the mothers’ knowledge of
partner treatment (place, type of treatment etc.) were captured.
When the mother failed to attend, the study team performed a
follow-up telephone call or home visit to the woman or recorded
next of kin. If the mother had experienced a stillbirth or neonatal
death in this pregnancy, she was offered counselling. If a baby
had signs or symptoms of congenital syphilis, a referral was
made to the National Referral Hospital for medical evaluation.
When the male partner attended the STI clinic as a result of a
notification, informed consent to collect study-related data was
obtained. Men underwent testing for syphilis using a rapid
treponemal antibody test followed by RPR confirmation. All
men attending were given syphilis treatment (as above) on the
same visit regardless of their syphilis results as per Ministry of
Health guidelines. Any partner attendance reported through
verbal confirmation by the mother or physical attendance by
the partner for treatment between the time of registration and the
maternal postnatal visit was included in the analysis.
Women received a small travel reimbursement (US$8), but
this was not given to male partners to avoid financial incentive
for attendance.
Sample size
The sample size was calculated using data from the IDI clinic
located within urban Kampala, where 220 pregnant women are
seen at the ANC per month, 5.1% of whom test positive for
syphilis,21 and the Mulago Hospital ANC, where, on average,
2000 pregnant women are seen monthly, with 2.4% testing
positive for syphilis.8 Based on a previous study at the IDI with
targeted counselling and SOC, we estimated that 50% of
women would notify their partners and that 60% of those
notified would attend the clinic in the SOC arm (overall 30%
of male partners).21 We hypothesised that if counselling and the
PN slip alone resulted in 30% partner attendance, then additional
interventionswith reminders (SMS, telephonecalls)wouldhavea
positive effect, resulting in increased partner attendance (for
gonorrhoea, 1 interview = 13% partner attendance vs >1
interview = 60% partner attendance22). In order to show a 50%
increase in the proportion of partners of women attending for
testing and treatment in the intervention arms (45% of male
partners overall), we estimated a sample size of 292 women
per arm with a total of 876 participants. To account for
multiple comparisons of the effect of each of the interventions
with the SOC arm, a Type 1 error (a) of 1.67% was set.
Data analysis
The primary outcome was the proportion of partners who
presented at the clinic and received syphilis testing or
treatment. Pearson’s Chi-squared statistic was used to test for
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significant differences among the three arms. In addition, the
proportion ofmenwho tested positive for syphilis, the proportion
who received syphilis treatment from theANCand those reported
by their spouse or partner to have received treatment elsewhere
were compared among arms using the Chi-squared statistic. For
some analyses we combined birth outcomes into positive
outcomes (live mother and baby) and negative, rarer, outcomes
(miscarriage, stillbirth, preterm labour, birth defects, neonatal
death as reported by the enrolled mothers). A multivariable
logistic regression model with robust standard errors was used
to establish factors associatedwith negativepregnancyoutcomes.
In this model, the notification arm was the primary exposure
variable, whereas age, marital status, employment and treatment
of partner for syphilis were considered potential confounders. All
analyses were performed using STATA15.1 (StataCorp, College
Station, TX, USA).
Ethics approvals
Ethics approval was obtained from the Ugandan Joint Clinical
Research Centre Institutional Review Board (IRB), the Uganda
National Council for Science and Technology (HS1681) and the
Johns Hopkins IRB (NA_00012998/CR00015330). The trial
was registered at Clinicaltrials.gov (NCT02262390). The study




January 2020) in methods and reporting.
Results
Syphilis screening
In all, 17 130 participants were interviewed between January
2015 and February 2016 (Fig. 1) and follow-up was completed
by April 2017. The median age of the pregnant women screened
was 25 years (interquartile range (IQR) 22–28 years), 15 094
(88.1%) were married and median parity was 2 (IQR 1–4); 601
(3.5%) tested positive for treponemal antibody. Of 16 805
women whose HIV status was known, 808 (4.8%) were HIV
positive. Syphilis prevalence was higher among HIV-positive
than -negative women (67/808 (8.3%) vs 535/16 322 (3.3%)
respectively). One-fifth (20.2%) of women reported a negative
outcome in a previous pregnancy (20.1% of those who were
syphilis negative vs 23.3% who were syphilis positive;
P < 0.001; Table S2). Of 601 women with positive syphilis
tests, 71 (11.8%) were not enrolled in the study because they did
not have a telephone, 55 (9.2%) were not enrolled because they
attended the clinic with their partner and 33 (5.5%) were not
enrolled for other reasons (Fig. 1). The number of women
attending with their partner for the first antenatal visit
increased over time (Fig. S1). Of 442 pregnant women
enrolled in the study, all were rapid test positive, 404
(91.4%) were RPR positive, 36 (8.1%) were RPR negative
and two RPR results (0.45%) were missing. Of the positive
RPRs at enrolment, 156/404 (38.6%) were 1 : 8. All women
who were treponemal antibody positive received BPG.
Study enrolment
Overall, 442 pregnant women were enrolled in the study: 152
(34.4%) in SOC arm, 144 (32.6%) in the SOC + SMS arm and
146 (33.0%) in the SOC + telephone call arm. Most participants
(362/442; 81.9%) were enrolled from the Mulago site, and 185
(41.9%) and 220 (49.8%) had primary- or secondary-level
education respectively. Most women were in their second
trimester (251/442; 56.8%), and 28 (6.3%) were HIV
positive (Table 2).
Postenrolment partner attendance
Postenrolment partner attendance at study sites was very low
(18.2%; 81/442). In the SOC, SOC + SMS and SOC + telephone
Screened 
(n = 17 130) 
Syphilis (positive) 
(n = 601) 
Mothers enrolled 
(n = 442) 
 
No telephone access (n = 71) 
Came with partner (n = 55) 
No interest (n = 10) 
Other (n = 11) 
No sex partner (n = 3) 
Cannot use telephone or SMS (n = 
3) 
Need to consult (n = 3) 
Not pregnant (n = 3) 
 
Followed-up postpartum 
(n = 396) 
Partners enrolled 
(n = 81) 
In person  
(blood 
drawn; 
n = 263) 
On 
telephone 
(n = 133) 
Excluded* 
(n = 159) 
Lost to follow-up 
(n = 46) 
SOC 
 
(n = 23/152; 
15.1%) 
SOC + SMS 
 
(n = 31/144; 
21.5%) 
SOC + phone 
 
(n = 27/146; 
18.5%) 
Fig. 1. Consolidated Standards of Reporting Trials (CONSORT) diagram. *Ten women had more than one reason for exclusion. SMS, short messaging
service (text message); SOC, standard of care (consisting of partner notification slips handed to women attending the clinic).
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call arms, 23 of 152 (15.1%), 31 of 144 (21.5%) and 27 of 146
(18.5%) partners returned to the study site respectively. There
were no significant differences between study-documented
postenrolment partner attendance by method of PN (Person’s
Chi-squared, P = 0.363; Table 3). An interim futility analysis
suggested that there would be no significant difference seen in
the arms of the study with the original sample, which led to
cessation of enrolment before the original sample size of the
study was reached.
The characteristics of the male partners who attended at
study sites are given in Table 4. The mother was not aware of
partner clinic attendance for 12 of 81 men (14.8%) who
reported for treatment at study sites. Of the 81 men who
attended clinic study sites, 21 (25.9%) tested positive for
syphilis; there was no difference in the rates of syphilis
positivity in male partners among the study arms
(P = 0.267). An additional 17 mothers reported that their
partners had attended a non-study clinic or health facility
for syphilis treatment, which increased the total rate to 98
of 442 male partners (22.2%) accessing treatment. When these
men were included in the analysis, 27 of 98 (22.2%) were in
the SOC arm, 35 (35.7%) were in the SMS arm and 36 (36.7%)
were in the telephone call arm (P = 0.151).
Mother and baby outcomes
In all, 396 enrolled women (89.6%) were followed-up by
telephone call (n = 133; 33.6%) or an in-person visit (n =
263; 66.4%): 136 (34.3%), 131(33.1%) and 129 (32.6%) from
the SOC, SOC + SMS and SOC + telephone call arms
respectively. Of these 396 women, only 22 did not give the
notification slip to their partner (10/136 (7.4%), 4/131 (3.1%)
and 8/129 (6.2%) in the SOC, SOC + SMS and SOC + telephone
call arms respectively). Among the women who were followed-
up, 372 (93.9%) had a healthy delivery at term, two (0.5%) had
preterm births, 13 (3.3%) had spontaneous or induced abortions
and nine (2.3%) had stillbirths. In all, there were 24 (6.1%)
negative pregnancy outcomes (preterm births, abortion,
Table 2. Baseline demographic and clinical characteristics of enrolled mothers
Unless indicated otherwise, data are given as n (%). IDI AIDC, Infectious Diseases Institute – Adult Infectious
Diseases Clinic; IQR, interquartile range; SMS, short messaging service (text message); SOC, standard of care













IDI AIDC 4 (2.6) 4 (2.8) 2 (1.4) 10 (2.3)
Mulago 129 (84.9) 118 (81.9) 115 (78.8) 362 (81.9)
Kasangati 19 (12.5) 22 (15.3) 29 (19.9) 70 (15.8)
Median [IQR] age (years) 26 [24–29] 27 [24–30] 26 [23–29] 26 [23–30]
Marital status
Monogamous marriage 111 (73.0) 96 (66.7) 119 (81.5) 326 (73.8)
Polygamous marriage 35 (23.0) 39 (27.1) 23 (15.7) 97 (22.0)
Separated or divorced 0 (0.0) 1 (0.7) 0 (0.0) 1 (0.2)
Single, regular partner 5 (3.3) 7 (4.9) 4 (2.7) 16 (3.6)
Single, irregular partner 1 (0.7) 1 (0.7) 0 (0.0) 2 (0.5)
Education level
None 0 (0.0) 1 (0.7) 0 (0.0) 1 (0.2)
Primary 54 (35.5) 67 (46.5) 64 (43.8) 185 (41.9)
Secondary 84 (55.3) 68 (47.2) 68(46.6) 220 (49.8)
Tertiary 13 (8.6) 7 (4.9) 14 (9.6) 34 (7.7)
Missing 1 (0.7) 1 (0.7) 0 (0.0) 2 (0.5)
Currently employed
Yes 70 (46.0) 88 (61.1) 77 (52.7) 235 (53.2)
HIV status
Negative 138 (90.8) 135 (93.7) 136 (93.2) 409 (92.5)
Positive 11 (7.2) 7 (4.9) 10 (6.8) 28 (6.3)
Missing 3 (2.0) 2 (1.4) 0 (0.0) 5 (1.1)
Gravida
1 14 (9.2) 12 (8.3) 18 (12.3) 44 (9.9)
2 36 (23.7) 30 (20.8) 33 (22.6) 99 (22.4)
3 102 (67.1) 102 (70.8) 95 (65.1) 299 (67.7)
Pregnancy planned
Yes 120 (79.0) 115 (80.4) 129 (88.4) 364 (82.5)
Pregnancy trimester
First 9 (5.9) 10 (6.9) 7 (4.8) 26 (5.9)
Second 83 (54.6) 76 (52.8) 92 (63.0) 251 (56.8)
Third 60 (39.5) 58 (40.3) 47 (22.2) 165(37.3)
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stillbirth, and miscarriages): 7/136 (5.2%), 11/131 (8.4%) and
6/129 (4.6%) in the SOC, SOC + SMS and SOC + telephone call
arms respectively (P = 0.386). Among the 86 women whose
partners received treatment for syphilis, two (2.3%)
experienced negative pregnancy outcomes, compared with
22 of the 310 women (7.1%) whose partners were not
treated (P = 0.127). In the multivariable logistic regression
model (Table 5), the risk of having a negative pregnancy
outcome increased significantly under the following
conditions: with every 5-year age increase, among women in
polygamous versus monogamous marriages, in women whose
partners were untreated for syphilis and for unemployed
women. In a sensitivity analysis where all women who were
lost to follow-up were considered to have negative pregnancy
outcomes, the results were similar.
Discussion
This is the first reported RCT of PN approaches to antenatal
syphilis in SSA and the first major trial of syphilis PN in
20 years. This study was large, screening over 17 000
pregnant women and recruiting over 400 female participants.
Syphilis seropositivity rates were high at 3.5%. The study tested
SOC index case notification against mobile phone-based
Table 3. Partner attendance according to study notification arm
The three study arms consisted of standard of care (SOC; a written partner notification slip (NS) was given to
the woman), SOC plus short messaging service (SMS) reminders and SOC plus telephone call reminders.
Unless indicated otherwise, data are given as n/N (%), where n is the number of partners attending and N is the













Partner attendance 23/152 (15.1) 31/144 (21.5) 27/146 (18.5) 81/442 (18.3)
IDI AIDC (n = 10) 0/4 (0.0) 1/4 (25.0) 1/2 (50.0) 2/10 (20.0)
Mulago (n = 362) 16/129 (12.4) 25/118 (21.2) 22 /115 (19.1) 63/362 (17.4)
Kasangati (n = 70) 7/19 (36.8) 5/22 (22.7) 4/29 (13.8) 16/70 (22.8)
Median (IQR) interval from
delivery of NS to woman
and partner clinic visit (days)
20 [5–35] 20 [6–42] 22 [7–30] 21 [6–35]
Table 4. Demographic characteristics of male partners enrolled in
the study
Unless indicated otherwise, data are given as n (%). IDI AIDC, Infectious
Diseases Institute – Adult Infectious Diseases Clinic; IQR, interquartile
range









IDI AIDC 2 (3.9) 0 (0.0) 2 (2.6)
Mulago 45 (76.3) 15 (79.0) 60 (76.9)
Kasangati 12 (20.3) 4 (21.0) 16 (20.5)
Median [IQR] age (years) 30 [26–39] 31 [28–38] 26 [23–30]
Marital status
Monogamous marriage 47 (79.7) 14 (73.7) 61 (78.2)
Polygamous marriage 12 (20.3) 5 (26.3) 17 (21.8)
Education level
None 1 (1.7) 1 (5.2) 2 (2.6)
Primary level 21 (35.6) 6 (31.6) 27 (34.6)
Secondary level 27 (45.7) 8 (42.1) 35 (44.8)
Tertiary 10 (17.0) 3 (15.8) 13 (16.7)
Professional qualifications 0 (0.0) 1 (5.2) 1 (1.3)
Currently employed
Yes 57 (96.6) 19 (100.0) 76 (97.4)
History of HIV testing
Negative 52 (88.1) 18 (94.7) 70 (89.7)
Positive 4 (6.8) 1 (5.3) 5 (6.5)
Never tested 3 (5.1) 0 (0.0) 3 (3.8)
Ever diagnosed with syphilis
Yes 6 (10.2) 10 (52.6) 16 (20.5)
AThree partners who returned to the clinic had missing syphilis test
results.
Table 5. Multiple logistic regressionmodel showing factors associated
with negative pregnancy outcomes among women who returned for
follow-up
The model was adjusted for reproductive history and HIV status.
Correlation between sites was accounted for using robust standard
errors. Negative outcomes include preterm births, abortion, stillbirth and
miscarriages. aOR, adjusted odds ratio; CI, confidence interval; SMS, short
messaging service (text message); SOC, standard of care (consisting of
partner notification slips handed to women attending the clinic)
Variable aOR (95% CI) P-value
Each 5-year increase in age 1.55 (1.33–1.79) <0.001
Marital status
Monogamous marriage 1
Polygamous marriage 2.59 (1.12–5.99) 0.025
Single or divorced 2.94 (0.04–226.40) 0.625
Employment status
Currently employed 1
Unemployed 1.19 (1.02–1.40) 0.028
Partner treated for syphilis
Yes 1
No 2.75 (2.36–3.21) <0.001
Notification arm
SOC 1
SOC + SMS 1.80 (0.96–3.38) 0.068
SOC + telephone call 0.99 (0.50–2.01) 0.996
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methods, which are cheap and widely available in SSA. Overall,
this study in Ugandan ANCs achieved a post-enrolment partner
attendance of 18.3%, with no significant differences seen
between the methods used (notification slip, telephone call or
SMS). A major finding of the study was that partner non-
treatment was independently and significantly associated
with adverse birth outcomes on multivariate analysis.
This study demonstrated much lower partner attendance
than previously published work. In Kenya, a partner
notification study in primary care showed 68% notified their
partner and 58% reported their partner had attended for STI
treatment.29 In Uganda, reported partner attendance rates have
been lower, at 25–34.5%.17,20,21 This low attendance rate was
a major limitation of the present study. A futility analysis was
undertaken, which led to enrolment being capped at 422 of the
876 planned enrolments; resources were not available to
markedly increase the sample size required to adequately
power the primary outcome. There are several reasons for
low attendance that highlight the limitations of the study,
including mothers not informing the male partner, the male
partner being informed but not attending, the male partner
attending but not telling the mother and male partners who
were more likely to receive treatment being screened out of the
study. These reasons are explored below.
Previous published studies on PN for STIs in RLS revealed
barriers including lack of knowledge of STIs, stigma, fear of
domestic violence, fear of revealing extramatrimonial partners
or an inability to contact casual partners.14 Therefore,
numerous cultural and systemic barriers exist at all stages
of the pathway from the point where the woman is diagnosed
with syphilis to the point where she informs her partner(s),
clinic attendance and the partner(s) receiving appropriate
testing and treatment. An additional limitation of the
present study and a key lesson learned is that we perhaps
did not go far enough to break down some of these barriers
despite our previous work in this area.21 Ideally, we should
have undertaken syphilis-specific intervention development
work with pregnant women, but our low-resource approach
did not allow for dedicated counselling time. We had
anticipated that a clinic-generated SMS shown to a partner
or a witnessed telephone call may have facilitated discussions
between partners. In a qualitative substudy we showed poor
partner communication, stigma and fear of intimate partner
violence as barriers to PN.30
Two recent studies have shown that those with an STI are
supportive of index case PN. In South Africa, 91% of men in a
high-risk group would prefer notification of an STI by slip
from their partner, but only 62.7% felt that an SMS from a
healthcare worker was acceptable.31 In Uganda, index case PN
was deemed highly acceptable by most groups, and HCPs
voiced concerns about limited time, resources and training for
provider-assisted approaches.32 These findings suggest that
index cases are prepared to inform their partners, but getting
partners to attend is the issue. Another limitation of the present
study is that we did not collect data on who had told their
partner, just whether the partner had attended or not.
The qualitative substudy identified limited knowledge of
syphilis as the main reason for a lack of partner attendance.30 In
order to strengthen our approach, a series of staged information
messages about syphilis via text message or voice call, rather
than just notification reminders, may have had more impact and
is worthy of future study. Another issue highlighted by the
qualitative work was the poor communication between
partners. Notably, 15% of men attended for treatment
without notifying their pregnant partner. This could also
have contributed to an underestimate of the number of men
attending for treatment.
The low partner attendance rate we saw may be due to the
exclusion of women who attended the ANC with their partner;
overall, we excluded 12% (74/601) of syphilis-positive women
whose partners attended with them, because these partners were
tested and treated for syphilis on the same day. The increase in
male partner attendance over time demonstrates that the
ongoing Ministry of Health strategy encouraging male
partner attendance at ANCs had a positive effect during the
course of this study. Therefore, we hypothesise that widespread
availability of syphilis and HIV testing for mothers and their
partners, along with patient educational interventions, could
improve syphilis screening uptake. It is striking that there were
relatively low rates of syphilis in the men who did attend for
testing (25.9%), challenging the assumption that untreated male
partners are the predominant driver of syphilis in pregnancy. We
speculate that thosemenwho did attendweremorewilling and/or
better able to engage with the health system and systematically
different from those who did not attend.
There is a possibility of unmeasured confounding by site
selection; there are disparities in care across healthcare settings
in Uganda generally, but inclusion of three different settings, all
with low partner attendance rates, may indicate the problem is
generalised across different settings. Other obstacles include
refurbishment of Mulago Hospital and consequent relocation of
the ANC, which created difficulties for mothers to attend
follow-up appointments within the study limits. This resulted
in missing post-treatment RPR data in many, making
conclusions about longitudinal RPR results impossible.
Previous work in Tanzania showed that women with high
syphilis RPR titres (>1 : 8) indicating active syphilis had a
stillbirth rate of 25% compared 1% in uninfected women
(risk ratio [RR], 18.1; P<.001);3 however, it is not possible
to infer whether negative pregnancy outcomes were likely due
to congenital syphilis in the present study.
Since this study was undertaken, Uganda has embraced
assisted PN for HIV testing alongside WHO encouragement
of this approach.33 Index cases found to be HIV positive enter
into an agreement with healthcare workers that they will notify
their partners within a certain time period. If they have not done
this by the time they are contacted again, the health worker
will undertake contact PN if the index case agrees.34 The HIV-
positive women are supported by counselling to help
communication with their partner, including strategies such
as role play if necessary. With this regulatory change, the
study team feels that assisted PN may be a preferable
method for syphilis PN moving forward. However, in our
qualitative work, mothers were concerned about intimate
partner violence against mothers who disclose partner details
or admit to having an STI, so this needs to be seriously
considered if men are to be contacted directly by HCPs.30
Regulatory frameworks covering non-HIV STIs would be
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welcome to support healthcare workers in choosing the best
method of PN, including assisted PN.
Conclusion
This study screened over 17 000 pregnant women and, by the
end of the study, 12% had attended the clinic with their male
partners but only 18% of men attended after receiving a partner
notification. Treatment of male partners for syphilis is
extremely important, as demonstrated by more negative birth
outcomes in women with untreated partners. SMS and
telephone calls remain potentially useful and underused tools
in STI partner management in RLS, but have not yet been fully
evaluated. Further studies to stop the cycle of reinfection of
mothers and congenital syphilis are needed, and the role of men
in the solution cannot be overlooked if progress is to be made.
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